Quest Diagnostics Incorporated
DGX
$195.23
-$3.38-1.70%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 245.00M | 245.00M | 282.00M | 220.00M | 222.00M |
| Total Depreciation and Amortization | 145.00M | 142.00M | 143.00M | 140.00M | 135.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.00M | 155.00M | 64.00M | 44.00M | 74.00M |
| Change in Net Operating Assets | 64.00M | 21.00M | 55.00M | -90.00M | 33.00M |
| Cash from Operations | 465.00M | 563.00M | 544.00M | 314.00M | 464.00M |
| Capital Expenditure | -158.00M | -144.00M | -108.00M | -117.00M | -123.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -50.00M | -34.00M | -17.00M | -- | -383.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.00M | -23.00M | 1.00M | 2.00M | 4.00M |
| Cash from Investing | -191.00M | -201.00M | -124.00M | -115.00M | -502.00M |
| Total Debt Issued | 0.00 | 10.00M | 185.00M | 215.00M | 0.00 |
| Total Debt Repaid | -1.00M | -10.00M | -401.00M | -600.00M | -1.00M |
| Issuance of Common Stock | 18.00M | 19.00M | 13.00M | 29.00M | 21.00M |
| Repurchase of Common Stock | -301.00M | -152.00M | 0.00 | -42.00M | -151.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -90.00M | -89.00M | -90.00M | -84.00M | -84.00M |
| Other Financing Activities | 87.00M | -25.00M | 0.00 | -79.00M | 45.00M |
| Cash from Financing | -287.00M | -247.00M | -293.00M | -561.00M | -170.00M |
| Foreign Exchange rate Adjustments | 1.00M | -2.00M | 4.00M | 1.00M | -7.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.00M | 113.00M | 131.00M | -361.00M | -215.00M |